A multicenter observational study of effectiveness and safety of nivolumab in non-small cell lung cancer in real clinical practice.

被引：0
|
作者：
Pozo, Juan Francisco Marin
Almazan, Macarena Merino
Perez, Juan Manuel Duarte
Vargas, Facundo Alberti
Sanz, Maria Paz Quesada
de Fuentes, Begona Muros
Garrido Martinez, Maria Teresa
Garrido Siles, Margarita
Martinez Bautista, Maria Jose
Martinez Diaz, Carmen
Gago Sanchez, Ana Isabel
Roldan Morales, Jose Carlos
Nieto Guindo, Pablo
Artacho Criado, Silvia Maria
Alvarado Fernandez, Maria Dolores
Mora Rodriguez, Beatriz
Artime-Rodriguez-Hermida, Fatima
Sanchez Rovira, Pedro
机构：
[1] Complejo Hosp Jaen, Pharm, Jaen, Spain
[2] Univ Granada, Dept Pharmacol, Granada, Spain
[3] Complejo Hosp Jaen, Med Oncol, Jaen, Spain
[4] Hosp Punta Europa, Pharm, Algeciras, Spain
[5] Hosp Virgen de la Victoria, Pharm, Malaga, Spain
[6] Hosp Juan Ramon Jimenez, Pharm, Huelva, Spain
[7] Hosp Costa del Sol, Pharm, Marbella, Spain
[8] Hosp Puerta del Mar, Cadiz, Spain
[9] Hosp Puerto Real, Pharm, Puerto Real, Spain
[10] Hosp Reina Sofia, Pharm, Cordoba, Spain
[11] Hosp SAS Linea, Pharm, La Linea, Spain
[12] Hosp Torrecardenas, Pharm, Almeria, Spain
[13] Hosp Valme, Pharm, Seville, Spain
[14] Hosp Virgen Macarena, Pharm, Seville, Spain
[15] Hosp Reg Univ Malaga, Pharm, Malaga, Spain
[16] Hosp Virgen Nieves, Pharm, Granada, Spain
[17] GEICAM Spanish Breast Canc Grp, Complejo Hosp Jaen, Jaen, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21092
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Effectiveness and safety of camrelizumab in inoperable or advanced non-small cell lung cancer patients: a multicenter real- world retrospective observational study (CTONG2004-ADV)
    Xu, Chong-Rui
    Chen, Qixun
    Zhou, Chengzhi
    Wu, Lin
    Li, Wen
    Zhang, Huizhong
    Li, Yongsheng
    Xu, Fei
    Xiong, Jianping
    Wang, Qiming
    Zhang, Haibo
    Jiang, Yuequan
    Yin, Haitao
    Wu, Qingchen
    Dai, Qiangsheng
    Hu, Jian
    Chen, Jianhua
    Zhang, Jian
    Wu, Gang
    Yin, Jun
    Zhao, Jianfu
    Liu, Baogang
    Shan, Jianzhen
    Sheng, Liming
    Chen, Qunqing
    Han, Zhengxiang
    Shi, Huaqiu
    Liu, Yimin
    Chen, Jun
    Wu, Yi-Long
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (01) : 127 - +
  • [22] Adverse events related to nivolumab in non-small cell lung cancer (NSCLC): a retrospective observational study
    Sassier, M.
    Oulkhouir, Y.
    Gervais, R.
    Alexandre, J.
    Humbert, X.
    Coquerel, A.
    Fedrizzi, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 31 - 32
  • [23] Observational study on the efficacy and safety of erlotinib in patients with non-small cell lung cancer
    Kaburagi, Takayuki
    Satoh, Hiroaki
    Hayashihara, Kenji
    Endo, Takeshi
    Hizawa, Nobuyuki
    Kurishima, Koichi
    Nishimura, Yoshihiro
    Hashimoto, Toshio
    Nakamura, Hiroyuki
    Kishi, Koji
    Inagaki, Masaharu
    Nawa, Takeshi
    Ichimura, Hideo
    Ishikawa, Hiroichi
    Kagohashi, Katsunori
    Fukuoka, Toshihiko
    Shinohara, Yoko
    Kamiyama, Koichi
    Sato, Yukio
    Sakai, Mitsuaki
    Matsumura, Takeshi
    Uchiumi, Keiko
    Furukawa, Kinya
    ONCOLOGY LETTERS, 2013, 5 (02) : 435 - 439
  • [24] Predictive Biomarkers of Response to Nivolumab in Non-Small Cell Lung Cancer: A Multicenter Retrospective Cohort Study
    Kataoka, Y.
    Hirano, K.
    Narabayashi, T.
    Hara, S.
    Fujimoto, D.
    Tanaka, T.
    Ebi, N.
    Tomii, K.
    Yoshioka, H.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1995 - S1995
  • [25] Nivolumab for treating non-small cell lung cancer
    Guibert, Nicolas
    Mazieres, Julien
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2015, 15 (12) : 1789 - 1797
  • [26] Nivolumab and Pembrolizumab for Non-Small Cell Lung Cancer
    Morgensztern, Daniel
    Herbst, Roy S.
    CLINICAL CANCER RESEARCH, 2016, 22 (15) : 3713 - 3717
  • [27] Perioperative Nivolumab in non-small cell Lung Cancer
    Lorenz, Judith
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2024, 149 (18) : 1065 - 1066
  • [28] The real-world experience with nivolumab in previously treated patients with advanced non small cell lung cancer (NSCLC): A Galician Lung Cancer Group clinical practice.
    Areses, M. C.
    Campelo, Rosario Garcia
    Gonzalez, Jorge Garcia
    Afonso, Francisco Javier
    Lazaro, Martin Emilio
    Campos, Begona
    Azpitarte, Cristina
    Amenedo, Margarita
    Santome, Lucia
    Ron, David Arias
    Alonso-Jaudenes, Guillermo
    Baron, Francisco
    Vilchez, Rocio
    Casal, Joaquin
    Fernandez, Natalia
    Carou, Iria
    Mosquera, Joaquin
    Anido, Urbana
    Mata, Jesus Garcia
    Firvida, Jose-Iuis
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [29] Multicenter cooperative observational study of idiopathic pulmonary fibrosis with non-small cell lung cancer
    Noriyuki Ebi
    Shoji Tokunaga
    Kazunobu Itoh
    Isamu Okamoto
    Nobutaka Edakuni
    Shinji Fujii
    Kentaro Watanabe
    Shinichiro Hayashi
    Takashige Maeyama
    Yoichi Nakanishi
    World Journal of Respirology, 2016, (01) : 42 - 48
  • [30] An observational study to assess the effectiveness and safety of cemiplimab in patients (pts) with advanced non-small cell lung cancer (NSCLC) in routine clinical practice within Europe (CEMI-LUNG)
    Gessner, Christian
    Griesinger, Frank
    Shah, Riyaz
    Talbot, Toby
    Venkateshan, Satish
    Krishna, Ashok
    Seluzhytsky, Alex
    Marsden, David
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 126 - 126
12345